Further Characterization of the Neuroendocrine Phenotype Associated With the PPOX-Related Variegate Porphyria

Pediatr Neurol. 2023 Dec:149:141-144. doi: 10.1016/j.pediatrneurol.2023.09.008. Epub 2023 Sep 20.

Abstract

Background: Variegate porphyria is caused by mutations in the PPOX gene; it usually presents in adolescents and adults as an autosomal dominant condition, with cutaneous features or acute peripheral and/or central nervous system crises. A rarer variant, homozygous variegate porphyria, presents in childhood with cutaneous manifestations as well as neurophenotypes. This study sought to further characterize the homozygous PPOX-related neuroendocrine phenotype.

Methods: This study is a retrospective review of the patients' charts, including their clinical evaluation and molecular genetics, neurodiagnostic, and neuroradiological investigations.

Results: We describe here three children from a consanguineous family who presented with nystagmus, developmental delay and ataxia, photosensitive skin manifestations, and adrenal insufficiency. Analysis of porphyrins in plasma, urine, and stool together with a genetic study of the PPOX gene confirmed the diagnosis. Interestingly, brain MRI showed severe hypomyelination, a finding rarely reported in variegate porphyria, together with adrenal insufficiency.

Conclusion: We recommend analysis of porphyrins in unexplained hypomyelination disorders. Patients with variegate porphyria should be tested for adrenal insufficiency.

Keywords: Adrenal insufficiency; MRI; PPOX; Variegate porphyria.

MeSH terms

  • Adrenal Insufficiency* / complications
  • Child
  • Flavoproteins / genetics
  • Humans
  • Mitochondrial Proteins / genetics
  • Phenotype
  • Porphyria, Variegate* / complications
  • Porphyria, Variegate* / genetics
  • Porphyrins*
  • Protoporphyrinogen Oxidase / genetics

Substances

  • Flavoproteins
  • Mitochondrial Proteins
  • Porphyrins
  • PPOX protein, human
  • Protoporphyrinogen Oxidase